ARCHIVES

ASCO’s Lichter Says. Dingell, Stupak Urge FDA To “Act With Due Haste To Avoid Endangering Patients” Steered To ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 09 | March 7, 2008

Download PDF Visit The Full Archive

Related Articles

In Brief: Henney Permanent NCI Deputy Director; 17 Regional Cooperative Group Applications Get First Review

February 5, 1982

Prostatic Cancer Workshop Reports On Etiology, Diagnosis, Treatment

September 10, 1976

FDA Continues Bureaucratic Delays Of Cancer INDs

January 30, 1976

In Brief: Sandor Eckhardt Is New UICC President; New Delhi Is Site Of 1994 UICC Meeting

August 31, 1990

NCI Advisors Approve $20.5M Program Of Grants, Contracts For Biospecimen Research.

July 6, 2007

Science Policy: Silicone Breast Implants Don’t Cause Disease

June 25, 1999